About: Agios Pharmaceuticals

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Agios Pharmaceuticals Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

a public American pharmaceutical company

Attributes	Values
rdf:type	Item
description	americká firma (cs) a public American pharmaceutical company (en) US-amerikanisches Pharmaunternehmen mit Hauptsitz in Cambridge (Massachusetts) (de)
rdfs:label	Agios Pharmaceuticals (de) Agios Pharmaceuticals (en) Agios Pharmaceuticals (es) Agios Pharmaceuticals (fr) Agios Pharmaceuticals (ga) Agios Pharmaceuticals (it) Agios Pharmaceuticals (nl) آجیوس (fa)
skos:prefLabel	Agios Pharmaceuticals (de) Agios Pharmaceuticals (en) Agios Pharmaceuticals (es) Agios Pharmaceuticals (fr) Agios Pharmaceuticals (ga) Agios Pharmaceuticals (it) Agios Pharmaceuticals (nl) آجیوس (fa)
name	Agios Pharmaceuticals (de) Agios Pharmaceuticals (en) Agios Pharmaceuticals (es) Agios Pharmaceuticals (fr) Agios Pharmaceuticals (ga) Agios Pharmaceuticals (it) Agios Pharmaceuticals (nl) آجیوس (fa)
ROR ID	wds:Q16824426-7698A775-0642-4250-AE59-DA411391F38C
ROR ID	002x06r10
instance of	wds:Q16824426-27B288E7-C093-4B88-9584-99058D3E3BF9 wds:Q16824426-409C0CA4-1EB7-4D42-BA4A-F5D406A78931
instance of	public company business
country	wds:Q16824426-2ee02e55-4e8c-0584-9d06-2727dc74221c
country	United States of America
Legal Entity Identifier	wds:Q16824426-B2D2ABB6-E4E3-41A8-B24D-4D6D69321258
Google Knowledge Graph ID	wds:Q16824426-01F11E7D-7141-4FAB-99E0-F4B95F498011
Open Funder Registry funder ID	wds:Q16824426-216ADA22-84E2-4736-BDD2-BDA35A9E28EB
Ringgold ID	wds:Q16824426-858CCCEF-43F8-4C4E-A73C-C70EDF96D111
Legal Entity Identifier	https://rdf.gleif.org/L1/L-529900ONJHY8EOGYT555
Google Knowledge Graph ID	http://g.co/kg/g/12mkwfw_g
Legal Entity Identifier	529900ONJHY8EOGYT555
Google Knowledge Graph ID	/g/12mkwfw_g
Open Funder Registry funder ID	100016471
Ringgold ID	333750
inception	wds:Q16824426-B02F0A76-85FA-4261-B123-50D9273032B4
inception	2008-01-01 00:00:00Z (xsd:dateTime)
headquarters location	wds:Q16824426-5C72CD40-8343-4936-AD2A-C23A0B058AA7
headquarters location	Cambridge
skos:altLabel	Agios Pharmaceuticals (United States) (en) Agios Pharmaceuticals, Inc. (en)
X username	wds:Q16824426-01207570-D92E-420E-B64E-64FD96EE8DC7
Crunchbase organization ID	wds:Q16824426-6B918AC5-5244-4B73-A9AE-F6040CE40237
ISNI	wds:Q16824426-6948A6CB-CCC6-4AAA-8780-A8CAA31DD0F7
Microsoft Academic ID	wds:Q16824426-6C6D7E68-96AD-487E-BF15-84B6090CF0DA
Golden ID	wds:Q16824426-82705198-4AEB-42C5-8920-A30EAAEFABB5
official website	wds:Q16824426-6038dd7e-40ed-03eb-577a-e7766d0e903e
social media followers	wds:Q16824426-25cd5019-98b8-4c07-aada-1b82ec3dac49 wds:Q16824426-98e6f93d-f49b-4e6d-a814-e7bd605ec2dd
Microsoft Academic ID	https://makg.org/entity/1293070606
X username	agiospharma
Crunchbase organization ID	agios-pharmaceuticals
ISNI	0000000405395873
Microsoft Academic ID	1293070606
Golden ID	Agios_Pharmaceuticals-KR8VWB
official website	http://www.agios.com/
social media followers	1839 (xsd:decimal)
GRID ID	wds:Q16824426-94437D93-062F-48A5-8304-24A42609DE4D
stock exchange	wds:Q16824426-915947E8-4199-4515-9311-55D833C14567
industry	wds:Q16824426-d6859100-46d6-94a5-0916-e30cb630f934
Central Index Key	wds:Q16824426-b65426d1-21a6-47c2-8778-f7b2b5fc3ee2
GRID ID	grid.427815.d
stock exchange	Nasdaq
industry	pharmaceutical industry
Central Index Key	0001439222
is owl:sameAs of	Agios Pharmaceuticals
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q16824426 Agios Pharmaceuticals https://de.wikipedia.org/wiki/Agios_Pharmaceuticals https://fa.wikipedia.org/wiki/%D8%A2%D8%AC%DB%8C%D9%88%D8%B3
is affiliation of	David Schenkein
is represents of	wds:Q114837553-3ED756AA-56BE-4367-96C8-543AA71C8026 wds:Q114837553-DEC2FCCA-7693-4FB5-96F3-CD5295B4DD38
is affiliation of	wds:Q114837553-90CB2578-EDC0-4EBE-93B3-739C32749691
is employer of	Robert J. Bauer Dhara D. Shah Rohitash Jamwal Shyam Kamble Chandra Prakash Janice Ahn Vickie Zhang Audra N Boscoe Melissa L DiBacco
is owned by of	Methods of treating brain tumors using combination therapy Pyruvate kinase modulators and use thereof Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide Methods of using pyruvate kinase activators Pyruvate kinase activators for use in treating blood disorders
is sponsor of	Pyruvate Kinase Deficiency Global Longitudinal Registry

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software